A history of pediatric immunology

Pediatric Research

Volumn 57, Issue 3, 2005, Pages 458-468

  Stiehm, E Richard ^a   Johnston Jr , Richard B ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Children's Hospital Colorado   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DEAMINASE; DIPHTHERIA ANTIBODY; IMMUNOGLOBULIN;

B LYMPHOCYTE; COMBINED IMMUNODEFICIENCY; DERMATOMYOSITIS; DIPHTHERIA; GENE THERAPY; GRANULOMATOSIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTORY OF MEDICINE; HOST RESISTANCE; HUMAN; HYPERSENSITIVITY; IMMUNE DEFICIENCY; IMMUNE SYSTEM; IMMUNOLOGY; IMMUNOTHERAPY; NEPHRITIS; PEDIATRICIAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; THYMUS; VACCINATION;

ALLERGY AND IMMUNOLOGY; CONGRESSES; EDUCATION; FOUNDATIONS; HISTORY, 18TH CENTURY; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; PEDIATRICS; SOCIETIES;

EID: 14344254356     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/01.PDR.0000151692.05422.4C     Document Type: Review

References (134)

1. Jenner E 1798 An Inquiry into the Causes and Effects of the Variolae Vaccinae. Sampson-Low, London
2. Silverstein AM 1989 The royal experiment on immunity, 1721-1722. In: Silverstein AM (ed) A History of Immunology. Academic Press, San Diego, pp 24-37
3. Silverstein AM 1989 A History of Immunology. Academic Press, San Diego
4. Pasteur L 1885 Methode pour prevenir la rage apres morsure Compt Rendu Seances Acad Sci 17:765-774
5. Tauber AI, Chernyak L 1989 The birth of immunology. II. Metchnikoff and his critics. Cell Immunol 121:447-473
6. Metchnikoff E 1884 A disease of Daphnia caused by a yeast. A contribution to the theory of phagocytes as agents for attack on disease-causing organisms. Arch Pathol Anat Physiol Klin Med (Virchow's) 96:177-195 (English translation and commentary in Brock TD (ed) 1961 Milestones in Microbiology. American Society for Microbiology, Washington DC, pp 132-138)
7. Metchnikoff E 1884 A disease of Daphnia caused by a yeast. A contribution to the theory of phagocytes as agents for attack on disease-causing organisms. Arch Pathol Anat Physiol Klin Med (Virchow's) 96:177-195 (English translation and commentary in Brock TD (ed) 1961 Milestones in Microbiology. American Society for Microbiology, Washington DC, pp 132-138)
8. Nuttall G 1888 [No title] Z Hyg 4:353 (English translation in Bibel DJ 1988 Milestones in Immunology, a Historical Exploration. Science and Technology Publications, Madison, p 161)
9. Nuttall G 1888 [No title] Z Hyg 4:353 (English translation in Bibel DJ 1988 Milestones in Immunology, a Historical Exploration. Science and Technology Publications, Madison, p 161)
10. von Behring E, Kitasato S 1890 [No title] Dtsch Med Woch 16:1113-1114 (The mechanism of immunity in animals to diphtheria and tetanus. English translation and commentary in Brock TD op cit, pp 138-140)
11. von Behring E, Kitasato S 1890 [No title] Dtsch Med Woch 16:1113-1114 (The mechanism of immunity in animals to diphtheria and tetanus. English translation and commentary in Brock TD op cit, pp 138-140)
12. Pfeiffer R 1895 Weitere untersuchungen uber das wesen der cholera-immunitat und uber specifisch bactericide processe. Z Hyg Infect 18:1-16
13. Wright AE, Douglas SR 1903 An experimental investigation of the role of the blood fluids in connection with phagocytosis. Proc R Soc Ser B Biol Sci 72:357-370
14. Wright AE, Douglas SR 1904 Further observations on the role of the blood fluids in connection with phagocytosis. Proc R Soc Lond Ser B Biol Sci 73:128-142
15. Ward HK, Enders JF 1933 An analysis of the opsonic and tropic action of normal and immune sera based on experiments with the pneumococcus. J Exp Med 57:527-547
16. Johnston RB Jr, Klemperer MR, Alper CA, Rosen FS 1969 The enhancement of bacterial phagocytosis by serum. The role of complement components and two co-factors. J Exp Med 129:1275-1290
17. Cohen SG, Samter M 1992 Excerpts from Classics in Allergy, 2nd Ed. Symposia Foundation, Carlsbad, pp 1-211
18. Schloss OM 1912 A case of allergy to common foods. Am J Dis Child 3:341-362
19. Faber HK, McIntosh R 1966 History of the American Pediatric Society 1887-1965, McGraw-Hill, New York
20. Boyd E 1927 Growth of the thymus: its relation to status thymicolymphaticus and thymic symptoms. Am J Dis Child 33:867-879
21. Duffy BJ Jr, Fitzgerald PJ 1950 Thyroid cancer in childhood and adolescence: a report on 28 cases. Cancer 3:1018-1032
22. Bruton OC 1952 Agammaglobulinemia. Pediatrics 9:722-728
23. Schultz W 1922 Ueber eigenartige Halserkrankungen. Dtsch Med Wochenschr 48:1495-1497
24. Syllaba L, Henner K 1926 Contribution a L'independence de l'athetose double idiopathique et ongenitale: atteinte familiale, syndrome dystrophique, signe du reseau vasculaire conjonctival, integrite psychique. Rev Neurol (Paris) 1:541-562
25. Thorpe ES, Handley HE 1929 Chronic tetany and chronic mycelial stomatitis in a child aged four and one-half years. Am J Dis Child 38:328-338
26. Wiskott A 1937 Familiarer angeborener Morbus Werihofii? Aschr Kinderheilk 68:212-216
27. Moore HD 1919 Complementary and opsonic functions in their relation to immunity. A study of the serum of guinea pigs naturally deficient in complement. J Immunol 4:425-441
28. Glanzmann E, Riniker P 1950 Essentielle Lymphozytophthise: Ein neues Krankheitsbild der Sauglingspathologies. Ann Paediatr 175:1-32
29. Donohue WL 1953 Alymphocytosis. Pediatrics 11:129-139
30. Hitzig WH, Biro Z, Bosch H, Huser HJ 1958 Agammaglobulinamie und Alymphozytose mit Schwund des lymphatischen Gewebes. Helv Paediatr Acta 13:551-585
31. Tobler R, Cottier H 1958 Familliare Lymphopenie mit Agammaglobulinamie und schwerer Moniliase. Helv Paediatr Acta 13:313-338
32. Gitlin D, Craig JM 1963 The thymus and other lymphoid tissues in congenital agammaglobulinemia. I. Thymic alymphoplasia and lymphocytic hypoplasia and their relation to infection. Pediatrics 32:517-530
33. Hitzig WH, Landolt R, Muller G, Bodmer P 1971 Heterogeneity of phenotypic expression in a famity with Swiss-type agammaglobulinemia: observations on the acquisition of agammaglobulinemia. J Pediatr 78:968-980
34. Giblett ER, Anderson JE, Cohen F, Pollara B, Meuwissen HJ 1972 Adenosine deaminase deficiency in two patients with severely impaired cellular immunity. Lancet 2:1067-1069
35. Rosen FS 2000 A brief history of immunodeficiency disease. Immunol Rev 178:8-12
36. Rosen FS, Kevy SV, Merler E, Janeway CA, Gitlin D 1961 Recurrent bacterial infections and dysgamma-globulinemia: deficiency of 7S gamma-globulins in the presence of elevated 19S gamma-globulins. Report of two cases. Pediatrics 28:182-195
37. Sanford JP, Favour CB, Tribeman MS 1954 Absence of serum gamma globulins in an adult. N Engl J Med 250:1027-1029
38. West CD, Hong R, Holland NH 1962 Immunoglobulin levels from the newborn period to adulthood and in immunoglobulin deficiency states. J Clin Invest 41:2054-2064
39. Rockey JH, Hanson LA, Heremans JF, Kunkel HG 1964 Beta-2A agammaglobulinemia in two healthy men. J Lab Clin Med 43:423-433
40. Ogra PL, Karzon DT 1969 Distribution of poliovirus antibody in serum, nasopharynx and alimentary tract following segmental immunization of lower alimentary tract with poliovaccine. J Immunol 102:1423-1430
41. Ogra PL 1971 Effect of tonsillectomy and adenoidectomy on nasopharyngeal antibody response to poliovirus. N Engl J Med 284:59-64
42. Good RA, Dalmasso AP, Martinez C, Archer OK, Pierce JC, Papermaster BW 1962 The role of the thymus in development of immunologic capacity in rabbits and mice. J Exp Med 116:773-796
43. Miller JF 1961 Immunological function of the thymus. Lancet 2:748-749
44. Good RA 1954 Agammaglobulinemia - a provocative experiment of nature. Bull Univ Minn Med Found 26:1-19
45. Cooper MD, Perey DY, Peterson RD, Gabrielsen AE, Good RA 1968 The two-component concept of the lymphoid system. In: Bergsma D (ed) Immunologic Deficiency Diseases in Man. National Foundation, New York, pp 7-16
46. DiGeorge AM 1965 A new concept of the cellular basis of immunity (discussion). J Pediatr 67:907-908
47. Kostmann R 1956 Infantile genetic agranulocytosis (agranulocytosis infantalis hereditaria): a new recessive lethal disease in man. Acta Paediatr Scand 45(suppl 105):1-78
48. Farrar JE, Rohrer J, Conley ME 1996 Neutropenia in X-linked agammaglobulinemia. Clin Immunol Immunopathol 81:271-276
49. Conley ME, Park CL, Douglas SD 1986 Childhood common variable immunodeficiency with autoimmune disease. J Pediatr 108:915-922
50. Levy J, Espanol-Boren T, Thomas C, Fischer A, Tovo P, Bordigoni P, Resnick I, Fasth A, Baer M, Gomez I, Sanders EA, Tabone MD, Plantaz D, Etzioni A, Monafo V, Abinun M, Hammerstrom L, Abrabamsen T, Jones A, Finn A, Klemola T, DeVries E, Sanal O, Peitsch MC, Notarangelo LD 1997 Clinical spectrum of X-linked hyper-IgM syndrome. J Pediatr 131:47-54
51. Buckley RH, Schiff RI, Schiff SE, Market ML, Williams LW, Harville TO, Roberts JL. Puck JM 1997 Human severe combined immunodeficiency: genetic, phenotypic, and functional diversity in one hundred eight infants. J Pediatr 130:378-387
52. Lux SE, Johnston RB Jr, August CS, Say B, Penchaszadeh VB, Rosen FS, McKusick VA 1970 Chronic neutropenia and abnormal cellular immunity in cartilage-hair hypoplasia. N Engl J Med 282:231-236
53. Pastural E, Barrat FJ, Dufourcq-Lagelouse R, Certain S, Sanal O, Jabado N, Seger R, Griscelli C, Fischer A, de Saint Basille G 1997 Griscelli disease maps to chromosome 15q21 and is associated with mutations in the myosin-Va gene. Nat Genet 16:289-292
54. Mentzer WC Jr, Johnston RB Jr, Baehner RL, Nathan DG 1977 An unusual form of chronic neutropenia in a father and daughter with hypogammaglobulinemia. Br J Haematol 36:313-322
55. Wetzler M, Talpaz M, Kleinerman ES, King A, Huh YO, Gutterman JU, Kurzrock R 1990 A new familial immunodeficiency disorder characterized by severe neutropenia, a defective marrow release mechanism, and hypogammaglobulinemia. Am J Med 89:663-672
56. Hernandez PA, Gorlin RJ, Lukens JN, Taniuchi S, Bohinjec J, Francois F, Klotman ME, Diaz GA 2003 Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease. Nat Genet 34:70-74
57. Janeway CA, Craig J, Davidson M, Downey W, Gitlin D, Sullivan JC Hypergammaglobulinemia associated with severe recurrent and chronic nonspecific infection. Am J Dis Child 88:388-392
58. Berendes H, Bridges RA, Good RA 1957 A fatal granulomatosus of childhood: the clinical study of a new syndrome. Minn Med 40:309-312
59. Holmes B, Quie PG, Windhorst DB, Good RA 1966 Fatal granulomatous disease of childhood. An inborn abnormality of phagocytic function. Lancet 1:1225-1228
60. Quie PG, White JG, Holmes B, Good RA 1967 In vitro bactericidal capacity of human polymorphonuclear leukocytes: diminished activity in chronic granulomatous disease of childhood. J Clin Invest 46:668-679
61. Baehner RL, Nathan DG 1967 Leukocyte oxidase: defective activity in chronic granulomatous disease. Science 155:835-836
62. Baehner RL, Nathan DG 1968 Quantitative nitroblue tetrazolium test in chronic granulomatous disease. N Engl J Med 278:971-976
63. Curnutte JT, Whitten DM, Babior BM 1974 Defective superoxide production by granulocytes from patients with chronic granulomatous disease. N Engl J Med 290:593-597
64. Johnston RB Jr, Keele BB Jr, Misra HP, Lehmeyer JE, Webb LS, Baehner RL, Rajagopalan KV 1975 The role of superoxide anion generation in phagocytic bactericidal activity. Studies with normal and chronic granulomatous disease leukocytes. J Clin Invest 55:1357-1372
65. Dinauer MC, Orkin SH, Brown R, Jesaitis AJ, Parkos CA 1987 The glycoprotein encoded by the X-linked chronic granulomatous disease locus is a component of the neutrophil cytochrome b complex. Nature 327:717-720
66. Gallin JI, Malech HL, Weening RS, Curnutte JT, Quie PG, Jaffe HS, Ezekowitz RA, International Chronic Granulomatous Disease Cooperative Study Group 1991 A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. N Engl J Med 324:509-516
67. Winkelstein JA, Marino MC, Johnston RB Jr, Boyle J, Curnutte J, Gallin JI, Malech HL, Holland SM, Ochs H, Quie P, Buckley RH, Foster CB, Chanock SJ, Dickler H 2000 Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) 79:155-169
68. Roos D, Weening RS, Voetman AA, van Schaik MLJ, Bot AA, Meerhof LJ, Loos JA 1979 Protection of phagocytic leukocytes by endogenous glutathione: studies in a family with glutathione reductase deficiency. Blood 53:851-866
69. Roos D, Weening RS, Wyss SR, Aebi HE 1980 Protection of human neutrophils by endogenous catalase: studies with cells from catalase-deficient individuals J Clin Invest 65:1515-1522
70. Crowley CA, Curnutte JT, Rosin RE, Andre-Schwartz J, Gallin JI, Klempner M, Snyderman R, Southwick FS, Stossel TP, Babior BM 1980 An inherited abnormality of neutrophil adhesion. Its genetic transmission and its association with a missing protein. N Engl J Med 302:1163-1168
71. Arnaout MA, Pitt J, Cohen HJ, Melamed J, Rosen FS, Colten HR 1982 Deficiency of a granulocyte membrane glycoprotein (gp 150) in a boy with recurrent bacterial infections. N Engl J Med 306:693-699
72. Anderson DC, Schmalsteig FC, Finegold MJ, Hughes BJ, Rothlein R, Miller LJ, Kohl S, Tosi MF, Jacobs RL, Waldrop TC, Goldman AS, Shearer WT, Springer TA 1985 The severe and moderate phenotypes of heritable Mac-1, LFA-1 deficiency: their quantitative definition and relation to leukocyte dysfunction and clinical features. J Infect Dis 152:668-689
73. Etzioni A, Frydman M, Pollack S, Avidor I, Philips ML, Paulson JC, Gershoni-Baruch R 1992 Recurrent severe infections caused by a novel leukocyte adhesion deficiency. N Engl J Med 327:1789-1792
74. Boxer LA, Hedley-Whyte ET, Stossel TP 1974 Neutrophil actin dysfunction and abnormal neutrophil behavior. N Engl J Med 291:1093-1099
75. Howard T, Li Y, Torres M, Guerrero A, Coates T 1994 The 47-kD protein increased in neutrophil actin dysfunction with 47- and 89-kD protein abnormalities is lymphocyte-specific protein. Blood 83:231-241
76. Hill HR, Quie PG 1974 Raised serum-IgE levels and defective neutrophil chemotaxis in three children with eczema and recurrent bacterial infections. Lancet 1:183-187
77. Strauss RG, Bove KE, Jones JR, Mauer AM, Fulginiti VA 1974 An anomaly of neutrophil morphology with impaired function. N Engl J Med 290:478-484
78. Ambruso DR, Knall KC, Abell AN, Panepinto J, Kurkchubasche A, Thurman G, Gonzalez-Aller C, Hiester A, deBoer M, Harbeck RJ, Oyer R, Johnson GL, Roos D 2000 Human neutrophil immunodeficiency syndrome is associated with an inhibitory Rac2 mutation. Proc Natl Acad Sci USA 97:4654-4659
79. Jouanguy E, Altare F, Lamhamedi S, Revy P, Emile JF, Newport M, Levin M, Blanche S, Seboun E, Fischer A, Casanova JL 1996 Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guerin infection. N Engl J Med 335:1956-1961
80. Altare F, Durandy A, Lammas D, Emile JF, Lamhamedi S, Le Deist F, Drysdale P, Jouanguy E, Doffinger R, Bernaudin F, Jeppsson O, Gollob JA, Meinl E, Segal AW, Fischer A, Kumararatne D, Casanova JL 1998 Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science 280:1432-1435
81. Donaldson VH, Evans RR 1963 A biochemical abnormality in hereditary angioneurotic edema: absence of serum inhibitor of C′1-esterase. Am J Med 35:37-44
82. Rosen FS, Pensky J, Donaldson V, Charache P 1965 Hereditary angioneurotic edema: two genetic variants. Science 148:957-958
83. Klemperer MR, Woodworth HC, Rosen FS, Austen KF 1966 Hereditary deficiency of the second component of complement (C′2) in man. J Clin Invest 45:880-890
84. Alper CA, Propp RP, Klemperer MR, Rosen FS 1969 Inherited deficiency of the third component of human complement (C′3). J Clin Invest 48:553-557
85. Alper CA, Abramson N, Johnston RB Jr, Jandl JH, Rosen FS 1970 Increased susceptibility to infection associated with abnormalities of complement-mediated functions and of the third component of complement (C3). N Engl J Med 282:349-354
86. Spitzer RE, Vallota EH, Forristal J, Sudora E, Stitzel A, Davis NC, West CD 1969 Serum C′3 lytic system in patients with glomerulonephritis. Science 164:436-437
87. Vallota EH, Gotze O, Spiegelberg HL, Forristal J, West CD, Muller-Eberhard HJ 1974 A serum factor in chronic hypocomplementemic nephritis distinct from immunoglobulins and activating the alternative pathway of complement. J Exp Med 139:1249-1261
88. Ellman L, Green I, Judge F, Frank MM 1971 In vivo studies in C4-deficient guinea pigs. J Exp Med 134:162-175
89. Berkel AI, Loos M, Sanal O, Mauff O, Gungen Y, Ors U, Ersoy F, Yegin O 1979 Clinical and immunological studies in a case of selective complete C1q deficiency. Clin Exp Immunol 38:52-63
90. Moncada B, Day NK, Good RA, Windhorst DB 1972 Lupus erythematosus-like syndrome with a familial defect of complement. N Engl J Med 286:689-693
91. Winkelstein JA, Drachman RH 1968 Deficiency of pneumococcal serum opsonizing activity in sickle-cell disease. N Engl J Med 279:459-466
92. Johnston RB Jr, Newman SL, Struth AG 1973 An abnormality of the alternate pathway of complement activation in sickle-cell disease. N Engl J Med 288:803-808
93. Fireman P, Zuchowski DA, Taylor PM 1969 Development of human complement system. J Immunol 103:25-31
94. Sawyer MK, Forman ML, Kuplic LS, Stiehm ER 1971 Developmental aspects of the human complement system. Biol Neonate 19:148-162
95. Strunk RC, Fenton LJ, Gaines JA 1979 Alternative pathway of complement activation in full term and premature infants. Pediatr Res 13:641-643
96. Notarangelo LD, Chirico G, Chiara A, Columbo A, Rondini G, Plebani A, Martini A, Ugazio AG 1984 Activity of classical and alternative pathways of complement in preterm and small for gestational age infants. Pediatr Res 18:281-285
97. Newman SL, Vogler LB, Feigin RD, Johnston RB Jr 1978 Recurrent septicemia associated with congenital deficiency of C2 and partial deficiency of factor B and the alternative complement pathway. N Engl J Med 299:290-292
98. Winkelstein JA, Johnson JP, Swift AJ, Ferry F, Yolken R, Cork LC 1982 Genetically determined deficiency of the third component of complement in the dog: in vitro studies of the complement system and complement-mediated serum activities. J Immunol 129:2598-2602
99. Perlmutter DH, Colten HR 1987 Structure and expression of the complement genes. Pharmacol Ther 34:247-270
100. Trapp RG, Fletcher M, Forristal J, West CD 1987 C4 binding protein deficiency in a patient with atypical Behcet's disease. J Rheumatol 14:135-138
101. Ochs HD, Wedgwood RJ, Frank MM, Heller SR, Hosea SW 1983 The role of complement in the induction of antibody responses. Clin Exp Immunol 53:208-216
102. O'Neil KM, Ochs HD, Heller SR, Cork LC, Morris JM, Winkelstein JA 1988 Role of C3 in humoral immunity. Defective antibody production in C3-deficient dogs. J Immunol 140:1939-1945
103. Orkin SH, Daddona PE, Shewach DS, Markham AF, Bruns GA, Goff SC, Kelley WN 1983 Molecular cloning of human adenosine deaminase gene sequences. J Biol Chem 258:12753-12756
104. Takeshita T, Asao H, Ohtani K, Ishii N, Kumaki S, Tanaka N, Munakata H, Nakamura M, Sugamura K 1992 Cloning of the gamma chain of the human IL-2 receptor. Science 257:379-382
105. Tsukada S, Saffran DC, Rawlings DJ, Parolini O, Allen RC, Klisak I, Sparkes RS, Kubagawa H, Mohandas T, Quan S, Belmont JW, Cooper MD, Conley ME, Witte ON 1993 Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell 72:279-290
106. Vetrie D, Vorechovsky I, Sideras P, Holland J, Davies A, Flinter F, Hammerstrom L, Kinnon C, Levinsky R, Bobrow M, Smith CIE, Bentley DR 1993 The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature 361:226-233
107. Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L, Tagle DA, Smith S, Uziel T, Sfer S, Ashkenazi M, Pecker I, Sartiel A Gatti RA, Chessa L, Sanal O, Lavin ME, Jaspers NGJ, Taylor AMR, Arlett CF, Miki T, Weissman SM, Lovert M, Collins FS, Shiloh Y 1995 A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268:1749-1753
108. Ochs HD, Smith CIE, Puck JM (eds) 1999 Primary Immunodeficiency Diseases: A Molecular and Genetic Approach. Oxford University Press, New York
109. Hitzig WH 2003 The discovery of agammaglobulinaemia in 1952. Eur J Pediatr 162:289-304
110. 1982 Unexplained immunodeficiency and opportunistic infections in infants - New York, New Jersey, California. MMWR Morb Mortal Wkly Rep 31:665-667
111. Ammann AJ, Cowan MJ, Wara DW, Weintraub P, Dritz S, Goldman H, Perkins HA 1983 Acquired immunodeficiency in an infant: possible transmission by means of blood products. Lancet 1:956-958
112. Scott GB, Fischl MA, Klimas N, Fletcher MA, Dickinson GM, Levine RS, Parks WP 1985 Mothers of infants with the acquired immunodeficiency syndrome. Evidence for both symptomatic and asymptomatic carriers. JAMA 253:363-366
113. Ziegler JB, Cooper DA, Johnson RO, Gold J 1985 Postnatal transmission of AIDS-associated retrovirus from mother to infant. Lancet 1:896-898
114. Stiehm ER, Vink P 1991 Transmission of human immunodeficiency virus infection by breast-feeding. J Pediatr 118:410-412
115. Pizzo PA, Eddy J, Falloon J, Balis FM, Murphy RF, Moss H, Wolters P, Brouwers P, Jorosinski P, Rubin M, Broder S, Yarchoan R, Brunetti A, Maha M, Nusinoff-Lehrmen S, Poplack DO 1988 Effect of continuous intravenous infusion of zidovudine (AZT) in children with symptomatic HIV infection. N Engl J Med 319:889-896
116. Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, Van Dyke R, Beg M, Shearer W, Jocobsen RL, Jimenez E, O'Neil E, Bazin B, Delfraissey JF, Culnane M, Coombs R, Elkins M, Moye J, Stratton P, Balsley J 1994 Reduction of maternal-infant transmission of human immunodeficiency virus type I with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 331:1173-1180
117. Guay LA, Musoke P, Fleming T, Bagenda D, Alien M, Nakabiito C, Sherman J, Bakaki P, Ducar C, Deseyve M, Emel L, Mirochnick M, Fowler MG, Mofenson L, Miotti P, Dransfield K, Bray D, Mmiro F, Jackson JB 1999 Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 354:795-802
118. Barandun S, Castel V, Makula MF, Morell A, Plan R, Skvaril F 1975 Clinical tolerance and catabolism of plasmin-treated gamma-globulin for intravenous application. Vox Sang 28:157-175
119. Ammann AJ, Ashman RF, Buckley RH, Hardie WR, Krantman HJ, Nelson J, Ochs H, Stiehm ER, Tiller T, Wara DW, Wedgwood R 1982 Use of intravenous gammaglobulin in antibody immunodeficiency: results of a multicenter controlled trial. Clin Immunol Immunopathol 22:60-67
120. Imbach P, Barundun S, D'Apuzzo V, Baumgartner C, Hirt R, Morell A, Rossie E, Schoni M, Vest M, Wagner HP 1981 High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet 1:1228-1231
121. Furusho K, Kamiya T, Nakano H, Kiyosawa N, Shinomiya K, Hayashidera T, Tamura T, Hirose O, Manabe Y, Yokahama T 1984 High-dose intravenous gammaglobulin for Kawasaki disease. Lancet 2:1055-1058
122. Kazatchkine MD, Kaveri SV 2001 Immunomodulation of autoimmune and inflammatory disease with intravenous immune globulin. N Engl J Med 345:747-755
123. Gatti RA, Meuwissen HJ, Allen HD, Hong R, Good RA 1968 Immunological reconstitution of sex-linked lymphopenic immunological deficiency. Lancet 2:1366-1369
124. Bach FH, Albertini RJ, Joo P, Anderson JL, Bortin MM 1968 Bone-marrow transplantation in a patient with the Wiskott-Aldrich syndrome. Lancet 2:1364-1366
125. Muller-Ruchholtz W, Wottge HU, Muller-Hermelink HK 1976 Bone marrow transplantation in rats across strong histocompatibility barriers by selective elimination of lymphoid cells in donor marrow. Transplant Proc 8:537-541
126. Reisner Y, Itzicovitch L, Meshorer A, Sharon N 1978 Hematopoietic stem cell transplantation using mouse bone marrow and spleen cells fractionated by lectins. Proc Natl Acad Sci USA 75:2933-2936
127. Reinherz EL, Geha R, Rappeport JM, Wilson M, Penta AC, Hussey RE, Fitzgerald KA, Daley JF, Levine J, Rosen FS, Schlossman SF 1982 Reconstitution after transplantation with T lymphocyte-depleted HLA haplotype-mismatched bone marrow for severe combined immunodeficiency. Proc Natl Acad Sci USA 79:6047-6051
128. O'Reilly RJ, Dupont B, Pahwa S, Grimes E, Smithwick EM, Pahwa R, Schwartz S, Hansen JA, Siegal FP, Sorell M, Svejgaard A, Jersild C, Thomson M, Platz P, L'Esperance P, Good RA 1997 Reconstitution in severe combined immunodeficiency by transplantation of marrow from an unrelated donor. N Engl J Med 297:1311-1315
129. Gluckman E, Broxmeyer HA, Auerbach AD, Friedman HS, Douglas GW, Devergie A, Esperou H, Thierry D, Socie G, Lehn D 1989 Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med 321:1174-1178
130. Hershfield MS, Chaffee S, Sorensen RU 1993 Enzyme replacement therapy with polyethylene glycol-adenosine deaminase in adenosine deaminase deficiency: overview and case reports of three patients, including two now receiving gene therapy. Pediatr Res 33(suppl 1):S42-S43
131. Blaese RM 1993 Development of gene therapy for immunodeficiency: adenosine deaminase deficiency. Pediatr Res 33(suppl 1):S49-S55
132. Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, Gross F, Yvon E, Nusbaum P, Selz F, Hue C, Certain S, Casanova JL, Bousso P, Deist FL, Fischer A 2000 Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 288:669-672
133. Aiuti A, Vai S, Mortellaro A, Casorati G, Ficara F, Andolfi G, Terrari G, Tabucchi A, Carlucci F, Ochs HD, Notarangelo LD, Roncarolo MG, Bordignon C 2002 Immune reconstitution in ADA-SCID after PBL gene therapy and discontinuation of enzyme replacement. Nat Med 8:423-425
134. Hacein-Bey-Abina S, Von Kalle C, Schmidt M, McCormack MP, Wulffraat N, Leboulch P, Lim A, Osborae CS, Pawliuk R, Morillon E, Sorensen R, Forster A, Fraser P, Cohen JI, de Saint Basile G, Alexander I, Wintergerst U, Frebourg T, Aurias, A, Stoppa-Lyonnet D, Romana S, Radford-Weiss I, Gross F, Valensi F, Delabesse E, Macintyre E, Sigaux F, Soulier J, Leiva LE, Wissler M, Prinz C, Rabbitts TH, Le Deist F, Fischer A, Cavazzana-Calvo M 2003 LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302:415-419